The promise of mRNA technology seemed boundless after the success of the coronavirus vaccines, but Robert F. Kennedy Jr. has ...

Ravindra Uppaluri, MD, PhD, discusses the background regarding locally advanced head and neck cancer and what the trial design of KEYNOTE-689 entailed.

The debate continues over the potential of measurable residual disease to transform research and clinical care in hematology.

Introduction The global antimicrobial susceptibility testing (AST) market is experiencing significant growth, largely due to the escalating thr ...